Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT

Novo Nordisk is open to the ​idea of upgrading ‌its New York listing as part of efforts ​to raise the ​Danish weight-loss drugmaker's profile ⁠in the country, its ​chief executive told Financial ​Time...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。